CytoSorbents Corporation (CTSO)

[B52T38]

Agreed, Mike, OC (like many others on the this board) shares some great info. No guarantees, of course, but I'm always open to learning about other tech and opportunities. CTSO does seem to be the outlier among many US-based biotechs pursuing FDA approval; my knowledge of other biotechs is limited, but I can't think of another company that has decided to first get adoption and financial traction in Europe, then use the data and $ to design an FDA trial(s).

I have no doubt FDA approval will come for CTSO, mainly because there's no safety issues. So if the trial is designed correctly/coordinated properly with the FDA, I'm confident approval(s) will come. That 28 day mortality might be a tough nut to crack because the patients are so sick, but based on all the case studies, I'm sure there's a sound statistical correlation between the filter and reducing mortality. Hospitals and insurance providers don't supply product codes for worthless devices.

So in summary, I just want to be LOADED with CTSO when the first hints of FDA-anything start to be whispered. Given the lack of viable alternatives, and assuming a decent overall stock market, I would peg this as at least an $80 - $100 move in the first month after approval.